EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m
Villers-lès-Nancy, 3 August 2023 - 6:00 p.m. (CET)...…
46,700€
-2,91%
Echtzeit-Aktienkurs PHARMAGEST INT.INH.EO 0,2
Bid:
Ask:
Nachrichten zur PHARMAGEST INT.INH.EO 0,2 Aktie
XFRA : DIVIDEND/INTEREST INFORMATION - 03.07.2023 - FR0012882389
Das Instrument PHF FR0012882389 EQUASENS S.A.INH. EO 0,2 EQUITY wird cum Dividende/Zinsen gehandelt am 30.06.2023 und ex Dividende/Zinsen am…
EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
Villers-lès-Nancy, 9 June 2023 - 6:00 p.m. (CET)...…
EQUASENS: Q1 2023 revenue: +13.96% to €56.25m
Villers-lès-Nancy, 11 May 2023 - 6:00 p.m. (CET)...…
EQUASENS: 2022 Net Profit: +18.35% to €48.70m
Villers-lès-Nancy, 24 March 2023 - 6:00 p.m. (CET)...…
EQUASENS: FY 2022 revenue: +10.88% to €214.07m
Villers-lès-Nancy, 3 February 2023 - 6:00 p.m. (CET)...…
EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT
Villers-lès-Nancy, 20 January 2023 – 6:00 p.m. (CET)...…